241 related articles for article (PubMed ID: 7533698)
1. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
Lee CR; Balfour JA
Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
[TBL] [Abstract][Full Text] [Related]
2. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
Reginster JY; Franchimont P
Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
[TBL] [Abstract][Full Text] [Related]
3. Piroxicam-β-cyclodextrin: a GI safer piroxicam.
Scarpignato C
Curr Med Chem; 2013; 20(19):2415-37. PubMed ID: 23394552
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain.
Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F
Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775
[TBL] [Abstract][Full Text] [Related]
5. Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin.
Serni U
Eur J Rheumatol Inflamm; 1993; 12(4):47-54. PubMed ID: 7805704
[TBL] [Abstract][Full Text] [Related]
6. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain].
Dolci G; Ripari M; Pacifici L; Umile A
Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108
[TBL] [Abstract][Full Text] [Related]
7. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
Lister RE; Acerbi D; Cadel S
Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
[TBL] [Abstract][Full Text] [Related]
8. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases.
Todd PA; Clissold SP
Drugs; 1991 Apr; 41(4):625-46. PubMed ID: 1711963
[TBL] [Abstract][Full Text] [Related]
9. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
Wang D; Miller R; Zheng J; Hu C
J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
[TBL] [Abstract][Full Text] [Related]
10. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of tenoxicam--an overview.
Vischer TL
Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
[TBL] [Abstract][Full Text] [Related]
12. Macrocyclic molecules and their pharmacological applications.
Lasagna L
Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
[No Abstract] [Full Text] [Related]
13. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
[TBL] [Abstract][Full Text] [Related]
14. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
Warrington S
Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and gastrointestinal tolerability of beta-cyclodextrin-piroxicam and tenoxicam in the treatment of chronic osteoarthritis.
Bonardelli P; Oliani C; Monici Preti PA; Pellicanó P; Quattrocchi G
Clin Ther; 1990; 12(6):547-55. PubMed ID: 2289222
[TBL] [Abstract][Full Text] [Related]
16. Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-beta-cyclodextrin.
Bannwart B; Bertin P; Péhourcq F; Schaeverbeke T; Gillet P; Lefrançois G; Trèves R; Dehais J; Netter P; Gaucher A
Int J Clin Pharmacol Ther; 2001 Jan; 39(1):33-6. PubMed ID: 11204935
[TBL] [Abstract][Full Text] [Related]
17. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and beta-cyclodextrin, in healthy subjects under single dose and steady-state conditions.
Deroubaix X; Stockis A; Allemon AM; Lebacq E; Acerbi D; Ventura P
Eur J Clin Pharmacol; 1995; 47(6):531-6. PubMed ID: 7768257
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of tenoxicam--an overview.
Vischer TL
Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
Warrington S; Debbas N; Farthing M; Horton M; Umile A
Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
Dolci G; Ripari M; Pacifici L; Umile A
Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
